Search results for "emot"

showing 10 items of 5695 documents

Granulocyte–Macrophage Colony-Stimulating Factor in the Therapy of Adults with De Novo Acute Myeloblastic Leukemia: An Update of a Double-Blind Rando…

1997

We investigated whether granulocytemacrophage colony-stimulating factor (GMCSF) given concomitantly with chemotherapy (CT) improves the outcome of adults with de novo acute myeloblastic leukemia (AML) by increasing the efficacy of CT and reducing infections. CT included cytarabine (ara-C) daunorubicin, and etoposide (DAV) for induction and early consolidation therapy and one cycle with high-dose (patients aged ≤50 years) or intermediate-dose ara-C (patients aged >50 years) /daunorubicin for late consolidation therapy. Eighty patients were randomized after DAV 1 to receive either GM-CSF (Escherichia coli, 250 µg/m2 per day, s.c.) or placebo starting 48 h prior to DAV II and the subsequent co…

medicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentPlacebo-controlled studyPlaceboGastroenterologyExact testMedian follow-upInternal medicineCytarabinemedicineAbsolute neutrophil countPhysical therapybusinessEtoposidemedicine.drug
researchProduct

Toxisches Schock Syndrom

1990

We report about a one year old girl with toxic shock syndrome (TSS), which was confirmed by a significant rise of TSST-1 titers. In addition to known manifestations of TSS, to our knowledge this is the first report about development of polyserositis in this disease. Tumor necrosis factor (TNF) was elevated at initial evaluation and fell under treatment with cortisone. This finding is in contrast to in-vitro observations. We believe that the use of cortisone in TSS warrants further investigation.

medicine.medical_specialtyChemotherapygenetic structuresbusiness.industrymedicine.medical_treatmentToxic shock syndromebacterial infections and mycosesmedicine.diseaseGastroenterologyInternal medicinePediatrics Perinatology and Child HealthImmunologymedicineTumor necrosis factor alphaCortisonebusinessmedicine.drugKlinische Pädiatrie
researchProduct

The Effect of Erythropoietin on Tumor Oxygenation in Normal and Anemic Rats

1994

Anemia associated with malignancy is a common clinical problem. Its etiology is varied and includes nutritional causes, hemorrhage, hemolysis, bone marrow metastasis and hypoplasia, paraneoplastic syndromes, and chemotherapy1, with many patients presenting with anemia even before they receive cytotoxic therapy and even if their bone marrow is not invaded by tumor cells2. The response of tumors to standard radiotherapy and oxygen-dependent chemotherapy in these patients is often less satisfactory than in subjects with normal hemoglobin levels3. This is presumed to be due to the worsening of tumor oxygenation as a result of the decreased oxygen-carrying capacity of the blood in these anemic t…

medicine.medical_specialtyChemotherapymedicine.diagnostic_testbusiness.industryAnemiamedicine.medical_treatmentTumor OxygenationHematocritmedicine.diseaseMalignancyGastroenterologymedicine.anatomical_structureErythropoietinInternal medicinemedicineBone marrowSarcomabusinessmedicine.drug
researchProduct

Why Do We Have to Use Chemotherapy?

2018

The use of chemotherapy (CT) in localized rectal cancer (LARC) has two aims: first, to improve the local effect of radiotherapy by giving concomitant chemoradiation and second, to decrease systemic relapses by early treatment for occult micrometastatic disease or to shrink bulky local tumours. Neoadjuvant treatment is reserved for locally advanced disease, as defined by pelvic magnetic resonance imaging, a very useful and accurate tool to identify high-risk features for local or systemic relapse [1]. We are going to address why we have to use CT in LARC.

medicine.medical_specialtyChemotherapymedicine.diagnostic_testbusiness.industryColorectal cancermedicine.medical_treatmentMagnetic resonance imagingmedicine.diseaseOccultRadiation therapyNeoadjuvant treatmentLocally advanced diseaseConcomitantMedicineRadiologybusiness
researchProduct

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

1988

Abstract Thirty-six patients with relapsed acute lymphoblastic leukemia (ALL) and four with primary refractory ALL were treated with a regimen that included amsacrine, 200 mg/m2, intravenously daily for three days with cytarabine, 3 gm/m2, by infusion over three hours daily for five days. There were 27 remissions in the 36 relapsed patients and two in the four patients with primary refractory disease. Seventeen of the 23 patients with common ALL, four of the six with T-cell ALL, one of the three with B-cell ALL, and seven of eight whose cells were not characterized responded. Toxicity of this regimen was comparable to other reinduction regimens for ALL, but the side effects characteristic o…

medicine.medical_specialtyChemotherapymedicine.drug_classbusiness.industrymedicine.medical_treatmentImmunologyCell BiologyHematologymedicine.diseaseBiochemistryAntimetaboliteGastroenterologySurgeryRegimenRefractoryAcute lymphocytic leukemiaInternal medicineToxicitymedicineCytarabinebusinessAmsacrinemedicine.drugBlood
researchProduct

Application of remote online learning in oral histopathology teaching in China

2021

Background The aim of this study was to investigate the application of remote learning and virtual microscopy in oral histopathology teaching, a unique experience in China. The oral histopathology teaching in Nanjing Medical University has been extraordinary. Material and Methods 98 third-year dental students of Grade 2016 took oral histopathology theoretical course face-to-face in 2019 (Traditional group). The 94 participants of Grade 2017 took online oral histopathology course using digital methods(E-Learning platform and Virtual Simulation Experiment Teaching Center for Dentistry) in 2020. During the practical laboratory sessions, the students in both Traditional group and Online group o…

medicine.medical_specialtyChinaeducationStudents DentalRemote learningVirtual technologyEducation Distanceoral lichen planusepithelial dysplasiamedicineHumansLearningGeneral DentistryEducation DentalUNESCO:CIENCIAS MÉDICASMedical educationOral Medicine and PathologyOnline learningResearchQuestionnaireoral cancerTest (assessment)OtorhinolaryngologySurgeryHistopathologyPsychologyVirtual microscopyMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Response of patients with chronic Hepatitis B in one year of treatment with Major Autohemotherapy.

2018

The Hepatitis B (HVB) is one of the most common infectious diseases in the world, it’s wide geographical distribution is a health problem, especially on the African continent, with prevalence rate of 6.1% in the adult population. Current treatment requires prolonged therapy (most cases for the rest of life) with the aim of stopping viral replication, maintaining immunological stability, preventing progression of liver disease and the most feared complications such as cirrhosis and hepatic cancer
 There are multiple references that point to ozone therapy as an alternative in the treatment of Hepatitis B, because of the known and demonstrated antimicrobial and immunomodulatory properties…

medicine.medical_specialtyCirrhosisbiologybusiness.industryHepatitis B:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOzone therapyGastroenterologyAutohemotherapyLiver diseaseAntigenInternal medicineUNESCO::CIENCIAS MÉDICASmedicinebiology.proteinAntibodybusinessViral loadJournal of Ozone Therapy
researchProduct

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colore…

2020

International audience; BACKGROUND: Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES: to assess the efficacy and safety of regorafenib at it's approved dose in the older population. PATIENTS AND METHODS: This multicenter single-arm phase II enrolled patients ≥70 years old after the failure of fluoropyrimidine-based chemotherapy, anti-VEGF, and anti-EGFR treatment. The primary endpoint was disease control rate (DCR) 2 months after initiation of regorafenib (160 mg/day, 3 weeks on/1 week off). RESULTS: Forty-three patients were enrolled, with a median age of 77 years. The 2 months DCR wa…

medicine.medical_specialtyColorectal cancerPyridinesmedicine.medical_treatment[SDV]Life Sciences [q-bio]AdenocarcinomaGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineQuality of lifeRegorafenibInternal medicinemedicineClinical endpointHumans030212 general & internal medicineAdverse effectChemotherapybusiness.industryPhenylurea Compoundsmedicine.disease3. Good health[SDV] Life Sciences [q-bio]DiarrheaOncologychemistry030220 oncology & carcinogenesisToxicityQuality of LifeGeriatrics and Gerontologymedicine.symptombusinessColorectal Neoplasms
researchProduct

Socio-affective characteristics and properties of extrinsic feedback in physiotherapy

2000

Background and Purpose The usual approach in physiotherapy is to communicate the desired action by means of some combination of verbal instruction and explanation, visual demonstration and manual assistance. Patients' and physiotherapists' communication and acts express socio-affective elements which influence the atmosphere governing this interaction. The purpose of this study was to investigate the socio-affective characteristics of the verbal, visual and manual feedback given to their patients by physiotherapists in the performance of their duties. Method Data were collected by videotaping patient–physiotherapist interaction. Systematic observation was used to depict physiotherapists' an…

medicine.medical_specialtyCommunicationEmotionsReproducibility of ResultsPhysical Therapy Sports Therapy and RehabilitationProfessional-Patient RelationsMiddle AgedSequential organizationVerbal cuesNonverbal communicationAction (philosophy)Visual guidancePhysical therapymedicineHumansCuesPsychologyInformation feedbackPhysical Therapy ModalitiesAgedPhysiotherapy Research International
researchProduct

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNI…

2020

International audience; Introduction - Patients treated for malignancy are considered at risk of severe COVID-19. This exceptional pandemic has affected countries on every level, particularly health systems which are experiencing saturation. Like many countries, France is currently greatly exposed, and a complete reorganization of hospitals is ongoing. We propose here adaptations of diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic. Methods - French societies of gastroenterology and gastrointestinal (GI) oncology carried out this study to answer two main questions that have arisen (i) how can we limit high-risk situat…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDigestive cancerMEDLINEAntineoplastic AgentsFrench Clinical Practice Guidelines[SDV.CAN]Life Sciences [q-bio]/CancerComorbidityMalignancyBetacoronavirus03 medical and health sciences0302 clinical medicineHealth carePandemicDisease Transmission InfectiousHumansChemotherapyMedicineInfection controlIntensive care medicinePandemicsDigestive System Surgical ProceduresSocieties MedicalGastrointestinal NeoplasmsInfection ControlHepatologySARS-CoV-2business.industryGastroenterologyCOVID-19Evidence-based medicinemedicine.diseaseComorbidityPatient Care ManagementCOVID-19 infection3. Good health030220 oncology & carcinogenesisSurgery030211 gastroenterology & hepatologyFranceCoronavirus InfectionsbusinessDigestive and Liver Disease
researchProduct